window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

cell and gene therapy

  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Regulatory Affairs

    Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution

    Alexander Seyf, CEO of Autolomous, explains how collaboration—not competition—is the [...]

    June 10, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Regulatory Affairs

    Is Europe rising? How global pharma uncertainty is fuelling a new era for European innovation

    As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

    June 8, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Drug Development

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 30, 2025
  • Cell & Gene Therapy,Clinical Trials,Patient Centricity,Regulatory Affairs

    Digital shift aims to fix long-term gaps in cell and gene therapy trials

    Medable unveils a patient-first remote model to support 15-year safety [...]

    May 30, 2025
  • Cell & Gene Therapy

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 13, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 13, 2025
  • Cell & Gene Therapy,Technology and platforms

    Title21 appoints expert committee to support cell and gene therapy platform development

    May 7, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy

    Astraveus teams up with NecstGen to trial benchtop CAR-T manufacturing platform

    May 6, 2025
  • Cell & Gene Therapy,Market Access & Commercialization,Partnerships & Funding

    Cellevate consortium secures €1M Eurostars grant to boost iPSC manufacturing at scale

    April 29, 2025
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion
    Categories: Drug discovery, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Precision medicine, Research & Development, Technology and platforms
  • Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
    Categories: Biomanufacturing, CDMOs & Manufacturing, Drug Development, Manufacturing, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • Emalex wins US patent for ecopipam ODT as Tourette access program grows
    Categories: Clinical Development, Drug Development, FDA, Neurosciences, Pharmaceuticals and therapeutics, Rare Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top